Table of Contents Table of Contents
Previous Page  1442-1443 / 2953 Next Page
Information
Show Menu
Previous Page 1442-1443 / 2953 Next Page
Page Background

Remarks on IMRT for LA NSCLC

• IMRT is now an accepted standard for LA NSCLC

radiotherapy

• IMRT could reduce V20 and heart dose

• IMRT could increase patients’ compliance to

chemotherapy

• Ongoing trials will clarify us the role of PET-guided hypo-

fractionated boost and the best chemotherapy

combination

(these trials are made possible by the use

of IMRT!)

• New drugs will hopefully amplify the benefit of the

combined modality approach